<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060"><gtr:id>C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060</gtr:id><gtr:name>University of St Andrews</gtr:name><gtr:address><gtr:line1>College Gate</gtr:line1><gtr:line4>St. Andrews</gtr:line4><gtr:line5>Fife</gtr:line5><gtr:postCode>KY16 9AJ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:department>Cal Unit (Medical Faculty)</gtr:department><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060"><gtr:id>C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060</gtr:id><gtr:name>University of St Andrews</gtr:name><gtr:address><gtr:line1>College Gate</gtr:line1><gtr:line4>St. Andrews</gtr:line4><gtr:line5>Fife</gtr:line5><gtr:postCode>KY16 9AJ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F5A42111-9D47-44DE-BAE7-C3953030EAE7"><gtr:id>F5A42111-9D47-44DE-BAE7-C3953030EAE7</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>O'Hagan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/CADBF37C-228F-4D6A-94E4-9442C4F50C42"><gtr:id>CADBF37C-228F-4D6A-94E4-9442C4F50C42</gtr:id><gtr:firstName>Hai</gtr:firstName><gtr:surname>Deng</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1864EEAF-C6BC-494B-A03D-5E2AF12CAACF"><gtr:id>1864EEAF-C6BC-494B-A03D-5E2AF12CAACF</gtr:id><gtr:firstName>Andy</gtr:firstName><gtr:surname>Welch</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/47392C57-5F18-4CC2-95B0-B89998DB6E49"><gtr:id>47392C57-5F18-4CC2-95B0-B89998DB6E49</gtr:id><gtr:firstName>Lutz</gtr:firstName><gtr:surname>Schweiger</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802567"><gtr:id>A39B047F-B793-4D4E-AB85-8A96D26BF9FC</gtr:id><gtr:title>Transfer of fluorinase mediated C-18F bond formation technology to the clinical environment for tumor imaging by PET</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0802567</gtr:grantReference><gtr:abstractText>Several years ago the St Andrews laboratory isolated a very unusual enzyme in that it had the ability to form carbon-fluorine bonds from inorganic fluoride ion. This enzyme was isolated and the gene identified and over-expressed in E.coli. The enzyme has emerged as an extremely useful catalyst for incorporating the isotope F-18 into an organic molecule. Using other enzymes in combination with the fluorinase enzyme the St Andrews laboratory have been able to make several novel fluorine-18 labelled products in time scales (1-2 hours) suitable for exploring the products as imaging agents, by positron emission tomography. We have begun to collaborate with the Aberdeen lab and have some preliminary data which shows that one of these molecules is actively transported into breast cancer cells, and also that one of these compounds can suitably image a rat. This Discipline Hopping grant will give us the opportunity to combine the expertise of the labs and establish if the fluorinase mediated catalysis of 18F-C bonds can be transferred into a clinical hot laboratory environment, and to establish if some of the molecules that can be prepared enzymatically have potential as imaging agents for cancer (oncology) and/ imaging the brain (neurology).</gtr:abstractText><gtr:technicalSummary>Positron emission tomography (PET) is growing rapidly through the Western world and developing countries as a diagnostic imaging tool for cancers and degenerative neurological disorders. In general the link between fluorine chemistry and pharmaceutical/medical applications is growing and all indications are that this will continue. The fluorinase enzyme was discovered in 2002 in St Andrews (Nature 2002, 416, 279) and it has been over-expressed and its structure (X-ray) and mechanism elicidated (Nature, 2004, 427, 561). The enzyme catalyses a reaction of fluoride ion and SAM to generate 5 -FDA and L-methionine. It has attracted attention as an enzymatic method of generating C-F bonds from inorganic fluoride. The fluorinase offers an entirely new method for the catalysis of C-F bonds. 18F is an important isotope for PET. We have shown now that it works well as a catalyst for the synthesis of 18F-C bonds. The objective of this programme is to demonstrate now that the fluorinase technology can be practically transferred to the clinical environment for clinical imaging in a collaboration between St Andrews University Centre for Biomolecular Sciences, and the John Mallard PET Centre - Aberdeen University at Aberdeen Royal Infirmary.</gtr:technicalSummary><gtr:fund><gtr:end>2010-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>89484</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of St Andrews</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Chemistry St Andrews</gtr:department><gtr:description>Transfer of Fluorinase Technology</gtr:description><gtr:id>5645ED68-FE5A-417E-858A-33C00CB38CF3</gtr:id><gtr:impact>The collaboration (which was central to this grant) has already generated a lot of ideas for future projects involving our two groups (and probably other centres) as well as one publication and one further grant (listed in the relevant section).</gtr:impact><gtr:outcomeId>5BC6F86FFAA-1</gtr:outcomeId><gtr:partnerContribution>Expertise in chemical synthesis methods</gtr:partnerContribution><gtr:piContribution>We provide the life sciences end of the collaboration aimed at transferring the chemical technology of enzymatic fluorination from St Andrews University (where it was developed) to the imaging facilities at the University of Aberdeen</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Talk to Primary School Children</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>71838266-2F4F-4577-ABD4-78AE90D98DC1</gtr:id><gtr:impact>Talked to P7 (2008) and P5 (2011) class at local primary school about the role of a scientist and mentioned development of new ways of detecting cancer

School arranged a follow-up session in which children wrote thank-you letters and talked about the impact the talk had on them</gtr:impact><gtr:outcomeId>X6eK7jAuHjv</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008,2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>318250</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Standard Research</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EPSRC EP/I034734/1</gtr:fundingRef><gtr:id>0F6A1F2C-F91F-4470-9B06-66ACC2256581</gtr:id><gtr:outcomeId>EofUDbFg8NT</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>56005</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Standard Research</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/I034793/1</gtr:fundingRef><gtr:id>0AB2584F-5140-4E66-B154-FB935E1147C3</gtr:id><gtr:outcomeId>aTRzBd5s2hN</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>119993</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Follow-on grant</gtr:description><gtr:end>2011-06-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>45C9C287-208B-4361-816A-932D13B1DF62</gtr:id><gtr:outcomeId>mjtJkQYos880</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Novel PET labelling technique</gtr:description><gtr:grantRef>G0802567</gtr:grantRef><gtr:id>7C5F4DA7-1D24-4BE2-9835-590A14D55A8E</gtr:id><gtr:impact>Novel chemistry</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>LpnjgY98xVk</gtr:outcomeId><gtr:patentId>GB1110239.9</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>PET imaging with 5-(18-fluoro)ribose-protein conjugates</gtr:title><gtr:yearProtectionGranted>2011</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NCRI PET Methodology Panel</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3CD7145E-03A8-447C-B043-ACD5158CC593</gtr:id><gtr:outcomeId>WQxVXZ1bckq</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>In line with the aims of the grant the methodology for production of FDR (a potential cancer biomarker) was transferred to the Aberdeen PET unit. Work is ongoing to characterise this marker.</gtr:description><gtr:id>5895ED33-3037-4D42-8AA1-E967564D9917</gtr:id><gtr:impact>Initial characterisation and investigation of possible use in synthesis of new compounds ongoing</gtr:impact><gtr:outcomeId>SVfwTinYJyd</gtr:outcomeId><gtr:stage>Refinement.  Non-clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>FDR</gtr:title><gtr:type>Diagnostic Tool - Imaging</gtr:type><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>refined method for development of fluorodeoxyribose</gtr:description><gtr:id>07F68FF7-2721-4F1B-A33D-B1C72B368208</gtr:id><gtr:impact>work ongoing to test the usefulness of FDR as a biomarker of cancer and as a synthetic group for production of other PET tracers</gtr:impact><gtr:outcomeId>CGBRKtVPvat</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>FDR</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9B4AAE68-0F1B-4729-A302-53E8BDEFB143</gtr:id><gtr:title>Efficient bioconjugation of 5-fluoro-5-deoxy-ribose (FDR) to RGD peptides for positron emission tomography (PET) imaging of a(v)?(3) integrin receptor.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f945184222af1936eb2fc61124b7d864"><gtr:id>f945184222af1936eb2fc61124b7d864</gtr:id><gtr:otherNames>Dall'Angelo S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>pm_14436_26_23733207</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5137C944-A713-4EF1-AFCA-B0D82333D35A</gtr:id><gtr:title>An enzymatic route to 5-deoxy-5-[18F]fluoro-D-ribose, a [18F]-fluorinated sugar for PET imaging.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57f1fa57b97e0b18f24a307a587beea8"><gtr:id>57f1fa57b97e0b18f24a307a587beea8</gtr:id><gtr:otherNames>Onega M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>DFD635D9535</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6759D23-2ECF-4112-BABF-C789B7D31E0A</gtr:id><gtr:title>Tumour imaging by Positron Emission Tomography using fluorinase generated 5-[&amp;sup1;8F]fluoro-5-deoxyribose as a novel tracer.</gtr:title><gtr:parentPublicationTitle>Nuclear medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f945184222af1936eb2fc61124b7d864"><gtr:id>f945184222af1936eb2fc61124b7d864</gtr:id><gtr:otherNames>Dall'Angelo S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0969-8051</gtr:issn><gtr:outcomeId>pm_14436_26_23541025</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802567</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>